High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$30.4M
$30,429,358
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -50.0%
|
2026-04-01 | $1,590,890Large | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-04-01 | $90,622 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -33.3%
|
2026-03-23 | $1,498,623Large | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-03-23 | $85,366 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-03-02 | $490,314 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-03-02 | $27,409 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-03-02 | $60,304 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -17.1%
|
2026-03-02 | $1,049,507Large | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-02-23 | $84,968 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -20.0%
|
2026-02-23 | $1,491,638Large | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -10.4%
|
2026-02-04 | $825,853 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-02-04 | $47,059 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -20.5%
|
2026-02-03 | $265,413 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -37.2%
|
2026-02-03 | $4,659,584Large | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -26.0%
|
2026-02-02 | $4,317,009Large | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -16.2%
|
2026-02-02 | $245,896 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-01-20 | $147,556 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -14.3%
|
2026-01-20 | $2,590,384Large | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -11.1%
|
2025-12-15 | $2,525,322Large | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-12-15 | $143,850 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -10.0%
|
2025-12-01 | $2,624,459Large | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-12-01 | $149,498 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-11-24 | $23,687 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-11-24 | $120,882 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-11-24 | $405,645 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-11-24 | $2,132,292Large | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-11-17 | $147,390 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-11-17 | $2,587,939Large | S | Form 4 |